Health state utility values in locally advanced and metastatic breast cancer by treatment line: a systematic review

2016 ◽  
Vol 16 (5) ◽  
pp. 549-559 ◽  
Author(s):  
Noman Paracha ◽  
Per-Olof Thuresson ◽  
Santiago G. Moreno ◽  
Katherine S. MacGilchrist
2021 ◽  
Vol 28 (5) ◽  
pp. 4203-4212
Author(s):  
Tsuguo Iwatani ◽  
Shinichi Noto ◽  
Koichiro Tsugawa

We aimed to determine the dynamic trends in health state utility values (HSUVs) in patients with end-stage breast cancer. We selected 181 patients comprising 137 with primary breast cancer (PBC) and 44 with metastatic breast cancer (MBC) (28 survivors and 16 patients with MBC death). HSUVs were 0.90 and 0.89 in patients with PBC and 0.83 and 0.80 in those with MBC (survivors) at 6 and 3 months, respectively, before the end of the observation period; these values were 0.73 and 0.66, respectively, in those with MBC (deceased) during the aforementioned period. The root-mean-squared error (RMSE) for the decrease in HSUVs over 3 months was 0.10, 0.096, and 0.175 for patients with PBC, MBC (survivors), and MBC (deceased), respectively. One-way analysis of variance for differences in absolute error among the groups was significant (p = 0.0102). Multiple comparisons indicated a difference of 0.068 in absolute error between patients with PBC and those with MBC (deceased) (p = 0.0082). Patients with end-stage breast cancer had well-controlled HSUVs 3 months before death, with a sharp decline in HSUVs in the 3 months leading up to death.


Author(s):  
Ryan O’Reilly ◽  
Sayako Yokoyama ◽  
Justin Boyle ◽  
Jeffrey C. Kwong ◽  
Allison McGeer ◽  
...  

2010 ◽  
Vol 10 (5) ◽  
pp. 553-566 ◽  
Author(s):  
Tessa Peasgood ◽  
Sue E Ward ◽  
John Brazier

BMJ Open ◽  
2018 ◽  
Vol 8 (2) ◽  
pp. e019978
Author(s):  
Lucy Kanya ◽  
Nana Anokye ◽  
Jennifer M Ryan

IntroductionIncreasingly, assessment of healthcare technologies and interventions requires the assessment of both costs and utilities. Health state utility values (HSUVs) are measured using a range of generic and condition-specific measures. While reviews have identified that generic measures of HSUVs may lack validity in adults with conditions that result in physical disability, there is little information available on the methods used to obtain HSUVs in children and adolescents with disabilities. The objectives of this systematic review are to describe the methods used to obtain HSUVs, including mode of administration and psychometric properties, and provide summary statistics for HSUVs among children and adolescents with disabilities.Methods and analysisThe following databases will be searched from inception for English-language studies of any design: PubMed, PsychInfo, Medline, Scopus, CINAHL Plus, Econlit and EMBASE databases. Two reviewers will independently screen titles, abstracts and full text articles for studies reporting HSUVs and/or data on the psychometric properties of preference-based measures for children and adolescents with disabilities aged up to 19 years. Two reviewers will independently extract data items including descriptors of the study methods and sample, instruments used to capture HSUVs, summary statistics for HSUVs and items relating to the quality of reporting. A descriptive summary of results from included studies and summary statistics for HSUVs will be presented. If sufficient data is identified, we will pool summary statistics for HSUVs according to the method used to obtain the HSUV using a random effects model. In addition, we will explore the determinants of the HSUVs using a meta-regression.Ethics and disseminationEthical approval will not be required as no original data will be collected as part of this review. The completed review will be submitted for publication in a peer-reviewed journal and presentation at conferences.PROSPERO registration numberCRD42018086574.


Sign in / Sign up

Export Citation Format

Share Document